移植患者感染并发症的免疫监测:改善临床管理的重要一步
实体器官移植后免疫重建对预防感染并发症至关重要,但监测免疫重建动力学仍具挑战。本文评论Chiereghin等对QuantiFERON-CMV试验评估心脏移植受者CMV特异性CD8+ T细胞免疫的研究,指出缺乏整体免疫反应者停用抗病毒预防后CMV风险更高,且首次病毒血症后未重建CMV特异性免疫与病毒复发相关,提示系统监测抗病毒免疫可作为预后工具并指导临床管理。
要点
- QFN-CMV试验中整体免疫反应缺失的移植患者停用抗病毒预防后CMV风险更高。
- 首次病毒血症缓解后未重建CMV特异性免疫与病毒复发相关。
- 系统监测抗病毒免疫可作为预后工具并指导移植患者临床管理调整。
核心结论
- 系统监测抗病毒免疫可成功用作预后工具并指导移植患者临床管理调整。
研究设计与样本
- 本文为对Chiereghin等在J Clin Microbiol发表的QuantiFERON-CMV试验评估研究的评论。
主要发现
- QFN-CMV试验中整体免疫反应缺失的患者停用抗病毒预防后发生CMV的风险更高。
- 首次病毒血症缓解后未能重建CMV特异性免疫与病毒复发相关。
临床怎么用
- 可利用QFN-CMV等工具系统监测移植患者抗病毒免疫以评估预后并指导临床管理调整。
局限性
- 许多新兴免疫监测平台技术过于复杂繁琐,难以在临床环境中实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune reconstitution following organ transplantation is absolutely critical in preventing infectious complications. However, understanding the kinetics of immune reconstitution and its potential impact on the clinical management of transplant patients remains a significant challenge. Over the last decade, various platform technologies have emerged which have provided important insights into the immune reconstitution kinetics in transplant patients. However, many of these technologies are too complicated and cumbersome to implement in a clinical setting. In this issue of the Journal of Clinical Microbiology, Chiereghin et al. (J. Clin. Microbiol. 56:e01040-17, 2018, https://doi.org/10.1128/JCM.01040-17) report the results of their evaluation of the QuantiFERON-CMV (QFN-CMV) assay to assess human cytomegalovirus (CMV)-specific CD8+ T-cell immunity in heart transplant recipients as a prognostic tool. These studies showed that patients with absence of global immune reactivity in the QFN-CMV assay were at a higher risk of developing CMV after discontinuing antiviral prophylaxis. Furthermore, failure to reconstitute CMV-specific immunity after resolution of the first episode of viremia was associated with viral relapse. These observations, along with other recent clinical studies utilizing the QFN-CMV assay, demonstrate that systematic monitoring of antiviral immunity can be successfully used as a prognostic tool and also to guide changes to the clinical management of transplant patients.
引用
- Khanna R. Immune Monitoring of Infectious Complications in Transplant Patients: an Important Step towards Improved Clinical Management. J Clin Microbiol. 2018. PMID: 29343541. doi:10.1128/JCM.02009-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。